THE EFFECT OF PAROXETINE ON THE QUANTITATIVE EEG

被引:23
作者
MCCLELLAND, GR
RAPTOPOULOS, P
JACKSON, D
机构
关键词
D O I
10.1111/j.1600-0447.1989.tb07173.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:50 / 52
页数:3
相关论文
共 7 条
[1]   AN EARLY CLINICAL PHASE-II EVALUATION OF PAROXETINE, A NEW POTENT AND SELECTIVE 5HT-UPTAKE INHIBITOR IN PATIENTS WITH DEPRESSIVE-ILLNESS [J].
BORUP, C ;
MEIDAHL, B ;
PETERSEN, IM ;
VANGTORP, A ;
HONORE, PL .
PHARMACOPSYCHIATRIA, 1982, 15 (06) :183-186
[2]   EEG AND HUMAN PSYCHOPHARMACOLOGY [J].
FINK, M .
ANNUAL REVIEW OF PHARMACOLOGY, 1969, 9 :241-+
[3]  
Itil T.M., 1974, PSYCHOTROPIC DRUGS H, VVolume 8, P43
[4]   FLUVOXAMINE (DU-23,000), A NEW ANTIDEPRESSANT - QUANTITATIVE PHARMACO-ELECTROENCEPHALOGRAPHY AND PILOT CLINICAL-TRIALS [J].
ITIL, TM ;
BHATTACHYARYYA, A ;
POLVAN, N ;
HUQUE, M ;
MENON, GN .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1977, 1 (3-4) :309-322
[5]   PAROXETINE IN THE TREATMENT OF DEPRESSION - A RANDOMIZED COMPARISON WITH AMITRIPTYLINE [J].
LAURSEN, AL ;
MIKKELSEN, PL ;
RASMUSSEN, S ;
HONORE, PL .
ACTA PSYCHIATRICA SCANDINAVICA, 1985, 71 (03) :249-255
[6]   EEG AND BLOOD LEVEL OF THE POTENTIAL ANTIDEPRESSANT PAROXETINE AFTER A SINGLE ORAL DOSE TO NORMAL VOLUNTEERS [J].
MCCLELLAND, GR ;
RAPTOPOULOS, P .
PSYCHOPHARMACOLOGY, 1984, 83 (04) :327-329
[7]  
SALETU B, 1983, BR J CLIN PHARM, V15, P369